Subscribe to MedHelp's free newsletter for Community Support, Experience, and Guidance.
Has your husband's protime and INR been tested? This is a simple finger stick blood test which measures coagulation speed. Normal INR is 1.0, atrial fib sufferers should have an INR of between 2.0 and 3.0. I would suggest strongly that your cardiologist be made aware of your concerns. At the same time, I also suggest that you request a protime and INR test.
rehab guidelines or physiotherapy accounts) highlighting the special circumstances and challenges sourrounding this group of patients. There is a lot of literature about secondary prevention of stroke but nothing about the special needs (physio, special hoists, chairs, oversize rhabilitation kit,etc.) and complications around rehabilitation of large patients.
Whereas the ADA used to recommend low-dose aspirin for every diabetic patient over the age of 40, their new guidelines suggest aspirin as a prevention strategy only in those with diabetes whose cardiovascular risk is above average. This includes men over age 50 or women over age 60 with at least one additional major risk factor. In other words, according to the ADA, younger diabetic patients without associated cardiovascular risk factors appear not to benefit from taking aspirin.
If you’re not monogamous, you’re not an ideal organ donor, according to a new set of health guidelines proposed by the Centers for Disease Control and Prevention.
Under the proposed policy, people who’ve had sex with two or more people in the past year will be considered high-risk for transmitting HIV, hepatitis B and hepatitis C, but transplant experts are arguing that the standards are far too limiting.
“With the new guidelines, every college student in America will be high-risk,” said Dr.
Primary prevention is a lot less effective than secondary prevention (as judged by the number needed to treat to prevent one stroke per year).Recent guidelines detail the evidence for primary prevention in stroke. Because stroke may indicate underlying atherosclerosis, it is important to determine the patient's risk for other cardiovascular diseases such as coronary heart disease. Conversely, aspirin prevents against first stroke in patients who have suffered a myocardial infarction.
Other observational studies support the risk of recurrent events associated with an atrial septal aneurysm. That said, the data for primary prevention is debated. Guidelines do support the use of Aspirin when an ASA and PFO coexist despite the lack of randomized data to support the therapy.
2. Can it be safely assumed that the TTE's results are accurate in regards to the PFO?
The ACC guideline recommend using aspirin (81 mg or more) in that group of patients, but the same guideline disclose that In patients younger than 60 y with lone Afib the risk of stroke or embolism is low without treatment and the effectiveness of aspirin for primary prevention of stroke relative to the risk of bleeding has not been established.
I have read some literature that says higher doses of aspirin are used for afib stroke prevention as well as some saying that even 30mg daily inhibits all platelets. I would like your thoughts on the newest findings regarding aspirin doses. Most importantly is 81mg enough? I am very active and do a lot of landscaping and I am also very concerned about the increased risk of bleeding from injury or trauma. Does aspirin greatly increase bleeding when one experiences a laceration?
Whereas the ADA used to recommend low-dose aspirin for every diabetic patient over the age of 40, their new guidelines suggest aspirin as a prevention strategy only in those with diabetes whose cardiovascular risk is above average. This includes men over age 50 or women over age 60 with at least one additional major risk factor. In other words, according to the ADA, younger diabetic patients without associated cardiovascular risk factors appear not to benefit from taking aspirin.
Whereas the ADA used to recommend low-dose aspirin for every diabetic patient over the age of 40, their new guidelines suggest aspirin as a prevention strategy only in those with diabetes whose cardiovascular risk is above average. This includes men over age 50 or women over age 60 with at least one additional major risk factor. In other words, according to the ADA, younger diabetic patients without associated cardiovascular risk factors appear not to benefit from taking aspirin.
I did about 3 strokes (2 with the direction of growth and 1 against) and then realized it was not my razor and stopped; the final stroke produced about a 5mm cut on my upper lip. I estimate the razor had not been used for about 36 hours or more.
A high cholesterol level was identified as a major risk factor in the development of heart disease in the 1970s. Lowering cholesterol for secondary prevention, that is preventing second heart attacks in persons who already had had one, was next demonstrated in the eighties and primary prevention of heart attack and stroke (In persons who had never had a prior event) demonstrated in the nineties.
What are the current guidelines for determining whether a person should take cholesterol lowering medication? Is it the LDL reading? The HDL reading? The ratio of Total to HDL?
Thanks.
The CFSAC must respectfully consider how it is contributing to the human rights abuse caused by the CFS construct, and demonstrate that it is forcefully acting in the best interests of these severely ill and neglected patients by becoming the Myalgic Encephalomyelitis Advisory Committee, strongly demanding the reinstatement of MyalgicEncephalomyelitis and the adaptation of a research version of the Canadian Consensus Guidelines, the only medically relevant guidelines with *diagnostic tests* an
A total cholesterol count of 214 is considered borderline. You didn't say what your hdl was. That number is important in interpreting your total reading. Take the ratio of total cholesterol (214) to hdl. If the ratio is less than 5, you are not in much danger (though 3.5 or less is ideal). Check out this website for more info:
http://www.americanheart.org/presenter.jhtml?
Previous randomized trials of statin use for lowering cholesterol have shown, on average, significant reduction in strokes in both primary and secondary prevention of about 15 to 30%. Hence the 27% reduction in stroke incidence is in keeping with the prior observations.
**************************************************************************************
Bottom line, there is a proven reduction in the risk of cardiac events with lower levels of serum LDL.
If the coronaries become too ectactic, we sometimes start a blood thinner called coumadin to prevent clots, although there are no guidelines for when to do this.
Marian Thamalarison at the Cleveland Clinic does not specialize in ectesia, but I trust his judgement and he is a very compassionate physician.
I hope this helps and thanks for posting.
BTW, your A-fib itself might present a greater stroke risk than plague formation. A-fib allows blood to stagnate in the atria and form tiny clots. Those clots can shot straight up through the carotid artery to the brain where they can occlude arteries and cause strokes. Or, they can increase back-pressure and cause rupture (bleeding) of a vessel that has been weakened by years of hypertension. I'm not trying to scare you.
The panel of outside medical experts voted 12-4 with one person abstaining on a question that asked whether the benefit of the drug offset the risks in patients without cardiovascular disease or who are currently considered at lower risk of developing the disease under current treatment guidelines.
The panel vote amounts to a recommendation that the FDA broaden the indication for Crestor as a preventative treatment for cardiovascular disease.
He moved in such a way that I penetrated him (I am circumsized) for one stroke for less than 3 seconds. He also gave me oral. Went to doctor next day and started PEP (Truvada) 14 hours after encounter. 1 week later, got an STD (Gonorrhea, NGU or Chlamydia) that doctor treated me for. Sent person an e-mail letting them know they were not std neg and confirm they were HIV - and they blew me off so know I am concerned about their status.
Lowering cholesterol for secondary prevention, that is preventing second heart attacks in persons who already had had one, was next demonstrated in the eighties and primary prevention of heart attack and stroke (In persons who had never had a prior event) demonstrated in the nineties. The most recently published studies have demonstrated that lipid lowering therapy decreases cardiac events even in those persons with normal cholesterol.
Recommended
